Literature DB >> 12133898

The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.

Nicole Wagner1, Kay-Dietrich Wagner, Gunnar Schley, Sarah E Coupland, Heinrich Heimann, Rosemarie Grantyn, Holger Scholz.   

Abstract

We have demonstrated recently that Wilms' tumor suppressor 1 (Wt1),in addition to its role in genitourinary formation,is required for the differentiation of ganglion cells in the developing retina. Here we provide further evidence that Wt1 is associated with neuronal differentiation. Thus, the retinoblastoma-derived human cell line, Y-79, contained robust amounts of Wt1 mRNA and protein. Wt1 expression was down-regulated upon laminin-induced differentiation of Y-79 into neuron-like cells. Inhibition of Wt1 with antisense oligonucleotides dramatically reduced the capacity of undifferentiated Y-79 cells to undergo neuronal differentiation, whereas sense and missense oligonucleotides had no effect. Wt1 immunoreactivity was also detected in solid retinoblastomas, in which it resided mainly in areas with moderate proliferative activity. These findings suggest a role for Wt1 in the differentiation of retinoblastoma cells. Furthermore, Wt1 expression in retinoblastoma may reflect the potential of these tumors to initiate the early steps of neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133898

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  9 in total

1.  The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.

Authors:  Nicole Wagner; John Panelos; Daniela Massi; Kay-Dietrich Wagner
Journal:  Pflugers Arch       Date:  2007-10-03       Impact factor: 3.657

2.  A mutation in the start codon of γ-crystallin D leads to nuclear cataracts in the Dahl SS/Jr-Ctr strain.

Authors:  Ashley C Johnson; Jonathan W Lee; Ashlyn C Harmon; Zaliya Morris; Xuexiang Wang; Jonathan Fratkin; John P Rapp; Elise Gomez-Sanchez; Michael R Garrett
Journal:  Mamm Genome       Date:  2013-02-13       Impact factor: 2.957

3.  The Drosophila Wilms׳ Tumor 1-Associating Protein (WTAP) homolog is required for eye development.

Authors:  Abigail M Anderson; Brandon P Weasner; Bonnie M Weasner; Justin P Kumar
Journal:  Dev Biol       Date:  2014-03-29       Impact factor: 3.582

4.  WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line.

Authors:  Sarah J Goodfellow; Michelle R Rebello; Eneda Toska; Leo A H Zeef; Sean G Rudd; Kathryn F Medler; Stefan G E Roberts
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

5.  Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastomas).

Authors:  M Wolk; J E Martin; M Nowicki
Journal:  Br J Cancer       Date:  2007-06-26       Impact factor: 7.640

6.  Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.

Authors:  Rosalba Parenti; Venera Cardile; Adriana Carol Eleonora Graziano; Carmela Parenti; Assunta Venuti; Maria Paola Bertuccio; Debora Lo Furno; Gaetano Magro
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells.

Authors:  Grazia Maugeri; Agata Grazia D'Amico; Daniela Maria Rasà; Rita Reitano; Salvatore Saccone; Concetta Federico; Rosalba Parenti; Gaetano Magro; Velia D'Agata
Journal:  Genes Cancer       Date:  2016-01

8.  Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation.

Authors:  Adriana Carol Eleonora Graziano; Venera Cardile; Rosanna Avola; Nunzio Vicario; Carmela Parenti; Lucia Salvatorelli; Gaetano Magro; Rosalba Parenti
Journal:  Oncotarget       Date:  2017-02-21

9.  Sex dependent glial-specific changes in the chromatin accessibility landscape in late-onset Alzheimer's disease brains.

Authors:  Julio Barrera; Lingyun Song; Julia E Gamache; Melanie E Garrett; Alexias Safi; Young Yun; Ivana Premasinghe; Daniel Sprague; Danielle Chipman; Jeffrey Li; Hélène Fradin; Karen Soldano; Raluca Gordân; Allison E Ashley-Koch; Gregory E Crawford; Ornit Chiba-Falek
Journal:  Mol Neurodegener       Date:  2021-08-24       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.